CONSULTING AGREEMENTConsulting Agreement • May 8th, 2020 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 8th, 2020 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is entered into on November 4, 2019, by and between Spero Therapeutics, Inc., a Delaware corporation, with its principal place of business being 675 Massachusetts Ave, Cambridge, MA 02139 (the “Company”), and Danforth Advisors, LLC, a Massachusetts limited liability corporation, with its principal place of business being 91 Middle Road, Southborough, MA 01772 (“Danforth”). The Company and Danforth are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”